Correlation Between Carl Zeiss and BioLife Sciences
Can any of the company-specific risk be diversified away by investing in both Carl Zeiss and BioLife Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Carl Zeiss and BioLife Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Carl Zeiss Meditec and BioLife Sciences, you can compare the effects of market volatilities on Carl Zeiss and BioLife Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Carl Zeiss with a short position of BioLife Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Carl Zeiss and BioLife Sciences.
Diversification Opportunities for Carl Zeiss and BioLife Sciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Carl and BioLife is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Carl Zeiss Meditec and BioLife Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLife Sciences and Carl Zeiss is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Carl Zeiss Meditec are associated (or correlated) with BioLife Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLife Sciences has no effect on the direction of Carl Zeiss i.e., Carl Zeiss and BioLife Sciences go up and down completely randomly.
Pair Corralation between Carl Zeiss and BioLife Sciences
Assuming the 90 days horizon Carl Zeiss Meditec is expected to under-perform the BioLife Sciences. But the pink sheet apears to be less risky and, when comparing its historical volatility, Carl Zeiss Meditec is 39.71 times less risky than BioLife Sciences. The pink sheet trades about -0.05 of its potential returns per unit of risk. The BioLife Sciences is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 0.80 in BioLife Sciences on September 3, 2024 and sell it today you would lose (0.79) from holding BioLife Sciences or give up 98.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Carl Zeiss Meditec vs. BioLife Sciences
Performance |
| Timeline |
| Carl Zeiss Meditec |
| BioLife Sciences |
Carl Zeiss and BioLife Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Carl Zeiss and BioLife Sciences
The main advantage of trading using opposite Carl Zeiss and BioLife Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Carl Zeiss position performs unexpectedly, BioLife Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLife Sciences will offset losses from the drop in BioLife Sciences' long position.| Carl Zeiss vs. BioLife Sciences | Carl Zeiss vs. CeCors Inc | Carl Zeiss vs. GlucoTrack | Carl Zeiss vs. Sharps Technology |
| BioLife Sciences vs. Innerscope Advertising Agency | BioLife Sciences vs. CeCors Inc | BioLife Sciences vs. GlucoTrack | BioLife Sciences vs. Sharps Technology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |